New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
07:46 EDTFPRXFive Prime price target raised to $20-$22 from $17-$19 at Wells Fargo
Wells Fargo increased its price target on Five Prime as the firm thinks the company's novel immunotherapy treatment targets have significant potential, and will likely enable the company to sign a partnership in the near-term. The firm continues to believe that the stock does not adequately reflect the company's long-term potential, and it keeps an Outperform rating on the shares.
News For FPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
16:23 EDTFPRXOn The Fly: Top stock stories for Wednesday
Stocks on Wall Street began the session in positive territory and never looked back. The market gained upside momentum during the first hour of trading, then found a level where it moved in a very narrow range throughout the day. The averages, led by the Nasdaq, recaptured a major part of yesterday’s losses with today's advance. ECONOMIC EVENTS: In the U.S., no major economic data was reported. COMPANY NEWS: Shares of Broadcom (BRCM) spiked after The Wall Street Journal reported that the company is in advanced talks to be acquired by Avago Technologies (AVGO). Piper Jaffray analyst Ruben Roy said that if average takeout multiples in the semiconductor space over the past several years are used as a guide, Broadcom could be valued near $58 per share in a takeover. Meanwhile, Pacific Crest speculated that Avago could pay $63-$65 per share for Broadcom and the deal would still be accretive. Later in afternoon, a report from Bloomberg claimed a stock and cash deal for Avago to acquire Broadcom could be announced as soon as tomorrow. Broadcom shares finished up $10.05, or 21.42%, to $56.97, while Avago ended with gains of $11.32, or 8.62%, to close the session at $142.62. MAJOR MOVERS: Among the notable gainers was Tiffany & Co. (TIF), which advanced $9.01, or 10.53%, to $94.54 after its earnings beat expectations and the company backed its forecast for fiscal year 2015. Also higher was Five Prime Therapeutics (FPRX), which rallied $2.89, or 14.69%, to $22.56 after it made a deal to develop CAR-T cancer therapies in partnership with bluebird bio (BLUE). Among the noteworthy losers was Michael Kors (KORS), which sank $14.66, or 24.2%, to $45.93 and was downgraded at BofA Merrill Lynch and JPMorgan after the company provided a weaker than expected outlook for the first quarter and fiscal year 2016. Also lower were shares of Workday (WDAY), which dropped $10.49, or 11.34%, to $82.00 after the company reported results and gave guidance with less upside than investors have come to expect. INDEXES: The Dow rose 121.45, or 0.67%, to 18,162.99, the Nasdaq gained 73.84, or 1.47%, to 5,106.59, and the S&P 500 advanced 19.28, or 0.92%, to 2,123.48.
11:09 EDTFPRXFive Prime surges after striking cancer partnership with bluebird bio
Subscribe for More Information
07:48 EDTFPRXFive Prime deal validates platform, says Oppenheimer
Subscribe for More Information
May 26, 2015
19:25 EDTFPRXOn The Fly: After Hours Movers
Subscribe for More Information
16:11 EDTFPRXFive Prime and bluebird bio enter into exclusive license agreement
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use